1 Min Read
* International Stem Cell Corp to expand its revenue generating biomedical businesses to support ongoing and future clinical trials Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.